Posted on 7/26/16
Embera NeuroTherapeutics Receives $11M Grant from NIDA
BOSTON & SHREVEPORT, La.--(BUSINESS WIRE)--Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and other addictions, today announced that it has received . . .
Posted on 7/26/16
X-Chem and AbbVie Enter into Multi-Target Drug Discovery Partnership
WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc., a privately held biotechnology company applying its cutting-edge lead discovery capabilities to the generation of novel small molecule therapeutics, today announced a . . .
Posted on 7/26/16
Animal Health Company Based on Forsyth Research Launched
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemming from research from the Forsyth Institute, a new animal health company, AIAH Therapeutics, LLC, will provide veterinarians and pet owners with a new . . .
Posted on 7/26/16
3 Top Biotech Stocks to Buy Now
IMAGE SOURCE: GETTY IMAGES.Back up the truck, let the tailgate down, and load up... with biotech stocks. That might seem like bad advice with many biotech . . .
Posted on 7/25/16
Medisafe Launches Commercial Offering for Pharmaceutical and Life Sciences Companies
Medisafe, the leading personalized medication management platform with three million patient and caregiver registered users, announced today the official launch of Medisafe for Pharma. Following a . . .
Posted on 7/25/16
Ocular Therapeutix Receives Complete Response Letter from FDA
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today . . .
Posted on 7/25/16
Alzheon Presents Positive Results of ALZ-801 Clinical Studies that Lead to Advancement to Pivotal Phase 3 Study in Alzheimer's Patients with APOE4/4 Homozygous Genotype
Pharmacokinetic and Safety Data from Phase 1b Studies with ALZ-801, an Optimized Prodrug of Tramiprosate, Presented at the Alzheimer's Association International ConferenceAlzheon Inc., today announced the . . .
Posted on 7/25/16
BIND Therapeutics Announces Two Bidders Join Pfizer’s Stalking Horse Bid in Auction for BIND’s Assets
BIND Therapeutics, Inc. (NASDAQ:BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS
Posted on 7/25/16
I Just Bought These 4 Fast-Growing Biotech Stocks
IMAGE SOURCE: GETTY IMAGES.The S&P 500 is currently trading near its all-time high, but that doesn't mean there aren't bargains on the market today. That's especially . . .
Posted on 7/25/16
Berkshire Hathaway Wants to Insure Your Doctor
IMAGE SOURCE: GETTY IMAGES.Warren Buffett has long been a fan of the insurance business at Berkshire Hathaway(NYSE:BRK-A)(NYSE:BRK-B). Managed correctly, insurers can win in two ways: by . . .
Posted on 7/25/16
Biogen Inc: How Double-Digit Growth Got Trumped
IMAGE SOURCE: GETTY IMAGES.Biogen (NASDAQ:BIIB) posted solid revenue and earnings growth when it released second-quarter earnings on Thursday. But the good earnings news was trumped by . . .
Posted on 7/25/16
Why athenahealth, Inc Shares Sank Today
IMAGE SOURCE: GETTY IMAGES.What: athenahealth (NASDAQ:ATHN) is down 12% at 12:00 p.m. ET after releasing earnings after market close on Thursday.So what: As fellow Fool Keith . . .
Posted on 7/25/16
Q2 Provider Gains Make Athenahealth Inc. Optimistic About Rest of the Year
IMAGE SOURCE: GETTY IMAGES."Unbreak healthcare." That's what athenahealth Inc. (NASDAQ:ATHN) states as its goal. And the healthcare technology company maintains that its products are the way . . .
Posted on 7/22/16
Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent
LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye diseases, . . .
Posted on 7/22/16
Madrigal Pharmaceuticals Completes Merger with Synta
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company focused on the development
Posted on 7/22/16
Why Investors Flocked to Sarepta Therapeutics This Week
IMAGE SOURCE: GETTY IMAGES.What: Sarepta Therapeutics (NASDAQ:SRPT) investors have been in a holding pattern since the FDA delayed a decision on the company's Duchenne muscular dystrophy . . .
Posted on 7/22/16
Metabolix Announces New Strategic Direction: Yield10 Bioscience to Become Core Business, Biopolymers Operations to be Wound Down
WOBURN, Mass., July 21, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that it is implementing a strategic restructuring under which Yield10 Bioscience will become . . .
Posted on 7/22/16
Biogen Reports Second Quarter 2016 Revenues of $2.9 Billion
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported second quarter 2016 financial results, including: Total revenues of $2.9 billion, a 12% increase versus the same period . . .
Posted on 7/22/16
American Renal Associates Holdings and Western Nephrology Announce Plans to Open the Kidney Center of the Rockies in the Vail Valley
BEVERLY, Mass. & DENVER--(BUSINESS WIRE)--American Renal Associates Holdings, Inc. (NYSE: ARA), a leading national provider of outpatient dialysis services, and Western Nephrology, one of the largest . . .
Posted on 7/21/16
Better Buy: CVS Health Corp vs. Express Scripts
IMAGE SOURCE: GETTY IMAGES.If you had invested $10,000 in CVS Health (NYSE:CVS) stock back in 2006 and held on for the ride, you'd now have over . . .
Posted on 7/21/16
Aegerion Pharmaceuticals Announces Cost Reduction Plans
CAMBRIDGE, Mass., July 20, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc.(NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with . . .
Posted on 7/20/16
Is Agenus or Ariad Pharmaceuticals the Better Long-Term Buy?
IMAGE SOURCE: GETTY IMAGES.With the global cancer market surpassing $100 billion in sales last year, and presently on track to hit $147 billion by as early . . .
Posted on 7/20/16
Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why
IMAGE SOURCE: GETTY IMAGES.Investors have been taken for quite the wild ride in 2016. Stocks opened the year with the worst two-week start in recorded history . . .
Posted on 7/20/16
AstroNova Earns Healthy Workplace Award from Blue Cross & Blue Shield of Rhode Island
WEST WARWICK, R.I.--(BUSINESS WIRE)--AstroNova, Inc. (NASDAQ: ALOT) announced today that it has received the Outstanding Worksite Health Award from Blue Cross & Blue Shield of Rhode . . .
Posted on 7/19/16
Selecta Biosciences Announces Gene Therapy Programs for Two Rare Genetic Metabolic Disorders
WATERTOWN, Mass., July 19, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, . . .
Boston
